VistaGen Therapeutics Inc (VTGN)

[ronpopeil]

av-101 will be more of a maintenance drug which is why i believe jnj is all over vtgn if they show efficacy and safety. esketamine should be approved soon but that can only be taken for so long. that is where av101 comes in. the big question is whether av 101 can be used as a mono therapy. if so, stock goes parabolic. vtgn is testing as an adjunctive too so we will see if that works as well so a few shots at the goal. it's nice to see them not dilute the crap out of the stock and only raising a little at a time to keep the company going, start new trials etc. av 101 could be a pipeline in of itself